(RTTNews) - Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biotechnology company, Monaday unveiled new preclinical and clinical data on icovamenib at the Advanced Technologies & Treatments for ...
(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and ...
Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin in both adults and youth with T1D Data to be featured ...
Poster highlights how healthcare expertise and lived screening experience together can help individuals move from awareness to action. RALEIGH, AL, UNITED STATES ...
RALEIGH, AL, UNITED STATES, March 11, 2026 / EINPresswire.com / — DiabetesSisters will present new insights on peer support and Type 1 diabetes screening engagement at the Advanced Technologies & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results